Inhibition of stromal CXCR4 impairs development of lung metastases

Potential of CXCR4 antagonists for the treatment of metastatic lung cancer

(2011) Jan A Burger et al.   Expert Review of Anticancer Therapy

Bone marrow-derived mesenchymal stem cells and the tumor microenvironment

(2010) Scott A. Bergfeld et al.   CANCER AND METASTASIS REVIEWS

Differential role of CD133 and CXCR4 in renal cell carcinoma

(2010) Crescenzo D’Alterio et al.   CELL CYCLE

Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer

(2010) C. D'Alterio et al.   CURRENT CANCER DRUG TARGETS

C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells

(2010) S. Hiratsuka et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expression of the chemokine receptor CXCR4 correlates with a favorable prognosis in patients with adenocarcinoma of the lung

(2009) Yoshihiro Minamiya et al.   LUNG CANCER

VEGFR1-activity-independent metastasis formation

(2009) Michelle R. Dawson et al.   NATURE

CXCR4 mediates the proliferation of glioblastoma progenitor cells

(2008) Moneeb Ehtesham et al.   CANCER LETTERS

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE